Delivery Order SPE2DB22D2005-SPE2DB25FJSX8
- Not listed
- The Defense Logistics Agency awarded a $27,237.60 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of TYPHIM VI 25 MCG/0.5 ML syringes, with an ultimate completion date of July 21, 2025. This non-set-aside contract reflects AmerisourceBergen's role as a critical pharmaceutical distributor supporting federal medical procurement needs. The delivery is designated for performance at the company's Corporate Office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of TYPHIM VI 25 MCG/0.5 ML syringes valued at $1,379.80. This is a firm fixed-price delivery order with an ultimate completion date of August 4, 2025, to be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract was awarded through open competition with no set-aside designation. This delivery order is issued under...
- The Defense Logistics Agency awarded a $3,449.50 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of TYPHIM VI 25 mcg/0.5 mL syringes. This non-competitive delivery order represents a single-line purchase of 0.5 mL syringes, with performance scheduled for completion by September 5, 2025. The contract will be fulfilled from AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania, where the company maintains its...
- The Defense Logistics Agency awarded a $1,694.07 firm fixed price delivery order to AmerisourceBergen Drug Corp for TYPHIM VI 25 MCG/0.5 ML syringes on August 29, 2025, with completion targeted for September 2, 2025. This non-set-aside delivery order represents a small-value transaction under AmerisourceBergen's larger pharmaceutical supply contract with DLA. The product will be delivered to the company's location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- The Defense Logistics Agency awarded a $4,584.55 firm fixed-price delivery order to AmerisourceBergen Drug Corp for TYPHIM VI 25 MCG/0.5 ML syringes. The contract, executed on August 25, 2025, with an ultimate completion date of August 26, 2025, represents a routine pharmaceutical procurement for military medical supply needs. This non-competitive delivery order will be performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania, where the company maintains its...
- The Defense Logistics Agency awarded a $2,796.14 delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for TYPHIM VI 25 MCG/0.5 ML syringes. This is a firm fixed-price, non-set-aside contract with a completion date of August 6, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal healthcare vendor that supplies vaccines, medications, medical devices, and...
- The Defense Logistics Agency awarded a $13,645.30 delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of TYPHIM VI 25 MCG/0.5 ML syringes. This competitively awarded, firm fixed-price contract is scheduled for completion by July 21, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of TYPHIM VI 25 MCG/0.5 ML syringes in 0.5 ML quantities, with a contract ceiling value of $6,899.00. This is a firm fixed-price delivery order with an ultimate completion date of September 5, 2025, and represents a non-set-aside competitive award. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- On July 23, 2025, the Defense Logistics Agency awarded a delivery order valued at $3,035.56 to AmerisourceBergen Drug Corp for TYPHIM VI 25 MCG/0.5 ML syringes (0.5 ML). This non-set-aside, firm fixed-price delivery order is scheduled for completion by July 24, 2025, with performance taking place at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's ongoing pharmaceutical supply relationship with the federal...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of TYPHIM VI 25 MCG/0.5 ML syringes valued at $10.75K with a completion date of August 4, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a small-value transaction within AmerisourceBergen's broader pharmaceutical distribution portfolio. The place of performance is located in Conshohocken, Pennsylvania, where the company...
- SPE2DB22D2005Indefinite Delivery Contract
- SPE2DB22D2005-SPE2DB25FJSX8Delivery Order
The Defense Logistics Agency awarded a $8,140.82 delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for TYPHIM VI 25 MCG/0.5 ML syringes. This non-competitive delivery order, classified as a Firm Fixed Price contract, will be performed at the company's corporate headquarters in Conshohocken, Pennsylvania, with an ultimate completion date of September 9, 2025. The award represents a routine pharmaceutical supply transaction executed through AmerisourceBergen's existing contract vehicle with the agency. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. As a major pharmaceutical distributor and healthcare solutions provider, AmerisourceBergen serves as a critical federal medical procurement vendor supplying vaccines, medications, and medical supplies to military and veteran healthcare systems. The company's comprehensive portfolio of federal awards demonstrates its capability to fulfill diverse pharmaceutical and medical supply requirements across multiple therapeutic domains for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Loading... | ||||